Chronically High Glucose: When Fuel Becomes a Pathological Signal

Chronically High Glucose: When Fuel Becomes a Pathological Signal

by Laurent Glatz – for Athletic Carnivore
*Podcast also available on Spotify.*

The Problem Is Not Glucose, But Its Chronic Repetition

The problem isn’t the presence of glucose itself. The problem lies in its chronic excess, its daily repetition, and especially the hormonal environment it creates.

Frequently elevated blood sugar forces the body to secrete more insulin and to maintain this hyperinsulinemia over time. This is where metabolic drift begins.

Fat tissue stores more easily, lipolysis slows down, hunger returns faster, leptin loses effectiveness, ghrelin becomes harder to regulate, cortisol worsens glycemic disturbances, and low-grade inflammation sets in.

Popular belief still reduces the issue to a simple question of “sugar in the blood.” The biological reality is harsher: chronic glucose imbalance eventually distorts the entire hormonal signaling, disrupts satiety, saturates storage pathways, and deregulates energy access.

Diabetes, Fatty Liver, Hypertension: Different Faces of the Same Process

The diseases most directly linked to this dynamic are well known but rarely considered as different manifestations of the same process. Type 2 diabetes doesn’t appear suddenly; it is the culmination of years of insulin resistance, compensatory hyperinsulinemia, unstable blood sugar, and the progressive inability of beta cells to keep up.

Visceral obesity contributes to this cycle by releasing more inflammatory signals and worsening insulin resistance. Non-alcoholic fatty liver disease follows the same logic: the liver, continuously exposed to excessive energy influx, converts an increasing share of this surplus into triglycerides, disrupts its own insulin sensitivity, and releases more glucose into the bloodstream.

Hypertension, metabolic syndrome, elevated triglycerides, and low HDL cholesterol are not isolated phenomena; they are markers of a metabolic terrain where glucose management loses flexibility.

Even clinical conditions like polycystic ovary syndrome fit into this physiology: hyperinsulinemia affects ovarian function, disrupts hormone production, and fosters an altered reproductive and metabolic environment.

Glycation, Inflammation, and Loss of Energy Control

The prevailing belief still tries to separate “weight diseases,” “sugar diseases,” cardiovascular diseases, and hormonal disorders. Biologically, this separation is weak.

Chronic excess glucose promotes glycation—the non-enzymatic alteration of proteins and cellular structures by circulating sugars. Advanced glycation end products degrade vascular flexibility, contribute to oxidative stress, and accelerate endothelial damage.

Elevated insulin also stimulates growth and storage pathways that alter tissue behavior far beyond simple glycemic control.

In the short term, this results in cravings, energy dips, compulsions, unstable recovery, and increasing difficulty mobilizing fat. In the long term, it creates the ground for retinal, kidney, nerve, and vascular complications, as well as chronic fatigue disguised as normality.

Many people live with so-called “still acceptable” blood sugar levels while already evolving in a dysregulated physiology driven by hyperinsulinemia, inflammation, and progressive loss of metabolic flexibility.

The Brain Is Not Immune to Glycemic Chaos

Brain impairments can no longer be considered separately. When blood sugar fluctuates sharply and insulin loses its effective signaling capacity, the brain is not spared from chaos.

Glycemic fluctuations influence alertness, mood, concentration, and energy stability. Over time, disrupted carbohydrate metabolism is linked to a higher risk of cognitive decline and neurological dysfunction.

Again, the problem isn’t a simple temporary glucose spike but repeated exposure to a hormonal and inflammatory environment that damages cells, membranes, microcirculation, and cerebral energy management.

Even some cancer trajectories are regularly discussed through this lens—not because sugar mechanically “causes” cancer alone, but because a terrain of hyperinsulinemia, chronic inflammation, and disordered anabolic signaling is never neutral for tissues exposed to prolonged dysregulation.

The Continuum That Recommendations Recognize Too Late

The blind spot of current recommendations lies here: they recognize terminal complications but often underestimate the biological continuum that precedes them.

We wait for blood sugar to cross a threshold, for weight to increase enough, for markers to degrade sufficiently, then we name the disease. Yet the process started long before, in the gap between what the body can handle and what we repeatedly impose on it.

Glucose is therefore not only involved in “diabetes.” It sits at the center of a network of pathologies where insulin resistance, storage, inflammation, hormonal dysregulation, and loss of energy control intersect.

The real question may no longer be whether your diet contains glucose, but how long your body can still tolerate its repeated elevations without paying the metabolic price of this modern normality.

#Glucose #Insulin #InsulinResistance #MetabolicSyndrome #Type2Diabetes #FattyLiver #ChronicInflammation #MetabolicHealth #LowCarb #AthleticCarnivore